Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay.

Berkhout LC, l'Ami MJ, Ruwaard J, Hart MH, Heer PO, Bloem K, Nurmohamed MT, van Vollenhoven RF, Boers M, Alvarez DF, Smith CH, Wolbink GJ, Rispens T.

Sci Transl Med. 2019 Jan 30;11(477). pii: eaat3356. doi: 10.1126/scitranslmed.aat3356.

PMID:
30700574
2.

Diffuse Gastric Ganglioneuromatosis: Novel Presentation of PTEN Hamartoma Syndrome-Case Report and Review of Gastric Ganglioneuromatous Proliferations and a Novel PTEN Gene Mutation.

Williams AJ, Doherty ES, Hart MH, Grider DJ.

Case Rep Med. 2018 Mar 25;2018:4319818. doi: 10.1155/2018/4319818. eCollection 2018.

3.

Response to: 'The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region' by Rinaudo-Gaujous et al.

van Schie KA, Hart MH, de Groot ER, Kruithof S, Aarden LA, Wolbink GJ, Rispens T.

Ann Rheum Dis. 2015 Aug;74(8):e41. doi: 10.1136/annrheumdis-2015-207529. Epub 2015 Apr 8. No abstract available.

PMID:
25854585
4.

TFPI inhibits lectin pathway of complement activation by direct interaction with MASP-2.

Keizer MP, Pouw RB, Kamp AM, Patiwael S, Marsman G, Hart MH, Zeerleder S, Kuijpers TW, Wouters D.

Eur J Immunol. 2015 Feb;45(2):544-50. doi: 10.1002/eji.201445070. Epub 2014 Nov 27.

5.

The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region.

van Schie KA, Hart MH, de Groot ER, Kruithof S, Aarden LA, Wolbink GJ, Rispens T.

Ann Rheum Dis. 2015 Jan;74(1):311-4. doi: 10.1136/annrheumdis-2014-206237. Epub 2014 Oct 23.

PMID:
25342759
6.

Functional analysis of the anti-adalimumab response using patient-derived monoclonal antibodies.

van Schouwenburg PA, Kruithof S, Votsmeier C, van Schie K, Hart MH, de Jong RN, van Buren EE, van Ham M, Aarden L, Wolbink G, Wouters D, Rispens T.

J Biol Chem. 2014 Dec 12;289(50):34482-8. doi: 10.1074/jbc.M114.615500. Epub 2014 Oct 17. Review.

7.

Drug interference in immunogenicity assays depends on valency.

Rispens T, Hart MH, Ooijevaar-de Heer P, van Leeuwen A, Vennegoor A, Killestein J, Wolbink GJ, van der Kleij D.

J Pharm Biomed Anal. 2013 Nov;85:179-85. doi: 10.1016/j.jpba.2013.07.022. Epub 2013 Jul 30.

PMID:
23954437
8.

The minipig as an alternative non-rodent model for immunogenicity testing using the TNFα blockers adalimumab and infliximab.

van Mierlo GJ, Cnubben NH, Wouters D, Wolbink GJ, Hart MH, Rispens T, Ganderup NC, Kuper CF, Aarden L, Penninks AH.

J Immunotoxicol. 2014 Jan-Mar;11(1):62-71. doi: 10.3109/1547691X.2013.796023. Epub 2013 Jun 5.

PMID:
23738746
9.

The Validity and reliability of the Comprehensive Home Environment Survey (CHES).

Pinard CA, Yaroch AL, Hart MH, Serrano EL, McFerren MM, Estabrooks PA.

Health Promot Pract. 2014 Jan;15(1):109-17. doi: 10.1177/1524839913477863. Epub 2013 Mar 7.

PMID:
23471699
10.

Smart choices for healthy families: a pilot study for the treatment of childhood obesity in low-income families.

Pinard CA, Hart MH, Hodgkins Y, Serrano EL, McFerren MM, Estabrooks PA.

Health Educ Behav. 2012 Aug;39(4):433-45. doi: 10.1177/1090198111425686. Epub 2012 Jan 3.

PMID:
22215734
11.

Patients non-responding to etanercept obtain lower etanercept concentrations compared with responding patients.

Jamnitski A, Krieckaert CL, Nurmohamed MT, Hart MH, Dijkmans BA, Aarden L, Voskuyl AE, Wolbink GJ.

Ann Rheum Dis. 2012 Jan;71(1):88-91. doi: 10.1136/annrheumdis-2011-200184. Epub 2011 Sep 12.

PMID:
21914626
12.

Measures of the home environment related to childhood obesity: a systematic review.

Pinard CA, Yaroch AL, Hart MH, Serrano EL, McFerren MM, Estabrooks PA.

Public Health Nutr. 2012 Jan;15(1):97-109. doi: 10.1017/S1368980011002059. Epub 2011 Sep 7. Review.

PMID:
21899786
13.

Differential effect of drug interference in immunogenicity assays.

Hart MH, de Vrieze H, Wouters D, Wolbink GJ, Killestein J, de Groot ER, Aarden LA, Rispens T.

J Immunol Methods. 2011 Sep 30;372(1-2):196-203. doi: 10.1016/j.jim.2011.07.019. Epub 2011 Jul 29.

PMID:
21824477
14.

Surprising negative association between IgG1 allotype disparity and anti-adalimumab formation: a cohort study.

Bartelds GM, de Groot E, Nurmohamed MT, Hart MH, van Eede PH, Wijbrandts CA, Crusius JB, Dijkmans BA, Tak PP, Aarden L, Wolbink GJ.

Arthritis Res Ther. 2010;12(6):R221. doi: 10.1186/ar3208. Epub 2010 Dec 27.

15.

A novel method for the detection of antibodies to adalimumab in the presence of drug reveals "hidden" immunogenicity in rheumatoid arthritis patients.

van Schouwenburg PA, Bartelds GM, Hart MH, Aarden L, Wolbink GJ, Wouters D.

J Immunol Methods. 2010 Oct 31;362(1-2):82-8. doi: 10.1016/j.jim.2010.09.005. Epub 2010 Sep 9.

PMID:
20833178
16.

Mannose-binding lectin deficiency facilitates abdominal Candida infections in patients with secondary peritonitis.

van Till JW, Modderman PW, de Boer M, Hart MH, Beld MG, Boermeester MA.

Clin Vaccine Immunol. 2008 Jan;15(1):65-70. Epub 2007 Oct 31.

17.

Deficiency of functional mannose-binding lectin is not associated with infections in patients with systemic lupus erythematosus.

Bultink IE, Hamann D, Seelen MA, Hart MH, Dijkmans BA, Daha MR, Voskuyl AE.

Arthritis Res Ther. 2006;8(6):R183.

18.

Variable mannose-binding lectin expression during postoperative acute-phase response.

Van Till JW, Boermeester MA, Modderman PW, Van Sandick JW, Hart MH, Gisbertz SS, Van Lanschot JJ, Aarden LA.

Surg Infect (Larchmt). 2006 Oct;7(5):443-52.

PMID:
17083310
19.

Mannan binding lectin in febrile adults: no correlation with microbial infection and complement activation.

Tacx AN, Groeneveld AB, Hart MH, Aarden LA, Hack CE.

J Clin Pathol. 2003 Dec;56(12):956-9.

20.

Crohn's disease presenting with Henoch-Schönlein purpura.

Saulsbury FT, Hart MH.

J Pediatr Gastroenterol Nutr. 2000 Aug;31(2):173-5. No abstract available.

PMID:
10941970
21.

Complicated PEG-to-skin level gastrostomy conversions: analysis of risk factors for tract disruption.

Romero R, Martinez FL, Robinson SY, Sullivan KM, Hart MH.

Gastrointest Endosc. 1996 Sep;44(3):230-4.

PMID:
8885338
22.

Peritoneal interleukin-8 in acute appendicitis.

Zeillemaker AM, Hoynck van Papendrecht AA, Hart MH, Roos D, Verbrugh HA, Leguit P.

J Surg Res. 1996 May;62(2):273-7.

PMID:
8632651
23.

Purification and characterization of the soluble interleukin-6 receptor from human plasma and identification of an isoform generated through alternative splicing.

Müller-Newen G, Köhne C, Keul R, Hemmann U, Müller-Esterl W, Wijdenes J, Brakenhoff JP, Hart MH, Heinrich PC.

Eur J Biochem. 1996 Mar 15;236(3):837-42.

24.

Soluble human interleukin-6 receptor. Expression in insect cells, purification and characterization.

Weiergräber O, Hemmann U, Küster A, Müller-Newen G, Schneider J, Rose-John S, Kurschat P, Brakenhoff JP, Hart MH, Stabel S, et al.

Eur J Biochem. 1995 Dec 1;234(2):661-9.

25.

The release of interleukin-8 during intravenous bolus treatment with interleukin-2.

Baars JW, Wolbink GJ, Hart MH, Hack CE, Eerenberg-Belmer AJ, Pinedo HM, Wagstaff J.

Ann Oncol. 1994 Dec;5(10):929-34.

PMID:
7696165
26.

Interleukin-8 (IL-8) in synovial fluid of rheumatoid and nonrheumatoid joint effusions.

Verburgh CA, Hart MH, Aarden LA, Swaak AJ.

Clin Rheumatol. 1993 Dec;12(4):494-9.

PMID:
8124912
27.

Chylous ascites following a Nissen fundoplication.

Parys SC, Hart MH.

J Pediatr Gastroenterol Nutr. 1992 Aug;15(2):181-3. No abstract available.

PMID:
1403467
28.
29.

Influence of portagen and pregestimil on essential fatty acid status in infantile liver disease.

Kaufman SS, Scrivner DJ, Murray ND, Vanderhoof JA, Hart MH, Antonson DL.

Pediatrics. 1992 Jan;89(1):151-4. No abstract available.

PMID:
1728003
30.

The intestinal absorption of 3-O-methyl-D-glucose in methotrexate-treated rats: an in vivo study of small bowel function.

Erdman SH, Hart MH, Park JH, Vanderhoof JA.

J Pediatr Gastroenterol Nutr. 1991 Nov;13(4):360-6.

PMID:
1779309
31.

Neonatal hepatitis and extrahepatic biliary atresia associated with cytomegalovirus infection in twins.

Hart MH, Kaufman SS, Vanderhoof JA, Erdman S, Linder J, Markin RS, Kruger R, Antonson DL.

Am J Dis Child. 1991 Mar;145(3):302-5.

PMID:
1848391
32.

Elevated plasma aluminum levels in normal infants receiving antacids containing aluminum.

Tsou VM, Young RM, Hart MH, Vanderhoof JA.

Pediatrics. 1991 Feb;87(2):148-51.

PMID:
1987526
33.

Suppression of diamine oxidase activity enhances postresection ileal proliferation in the rat.

Erdman SH, Park JH, Thompson JS, Grandjean CJ, Hart MH, Vanderhoof JA.

Gastroenterology. 1989 Jun;96(6):1533-8.

PMID:
2497042
34.

Acute self-limited colitis associated with Cryptosporidium in an immunocompetent patient.

Hart MH, Kruger R, Nielsen S, Kaufman S.

J Pediatr Gastroenterol Nutr. 1989 Apr;8(3):401-3.

PMID:
2709272
35.

Effects of dietary linoleic acid on mucosal adaptation after small bowel resection.

Park JH, Grandjean CJ, Hart MH, Baylor JM, Vanderhoof JA.

Digestion. 1989;44(2):57-65.

PMID:
2612750
36.

Essential fatty acid deficiency and postresection mucosal adaptation in the rat.

Hart MH, Grandjean CJ, Park JH, Erdman SH, Vanderhoof JA.

Gastroenterology. 1988 Mar;94(3):682-7.

PMID:
3338636
37.

Augmentation of postresection mucosal hyperplasia by plerocercoid growth factor (PGF). Analog of human growth hormone.

Hart MH, Phares CK, Erdman SH, Grandjean CJ, Park JH, Vanderhoof JA.

Dig Dis Sci. 1987 Nov;32(11):1275-80.

PMID:
3665682
38.

Failure of blind small bowel biopsy in the diagnosis of intestinal lymphangiectasia.

Hart MH, Vanderhoof JA, Antonson DL.

J Pediatr Gastroenterol Nutr. 1987 Sep-Oct;6(5):803-5.

PMID:
3694377
39.

Effect of pure zinc deficiency on glucose tolerance and insulin and glucagon levels.

Park JH, Grandjean CJ, Hart MH, Erdman SH, Pour P, Vanderhoof JA.

Am J Physiol. 1986 Sep;251(3 Pt 1):E273-8.

PMID:
3529981
40.

Cefamandole failure in Haemophilus influenzae endocarditis.

Hart MH, Cherry JD.

Pediatr Infect Dis. 1985 Nov-Dec;4(6):695-7. No abstract available.

PMID:
3878502
41.

Hereditary hemorrhagic telangiectasia.

Hart MH, Hodges RE.

Nebr Med J. 1983 Jun;68(6):157-61. No abstract available.

PMID:
6877422
43.
44.

Was the pre-biotic atmosphere of the earth heavily reducing?

Hart MH.

Orig Life. 1979 Sep;9(4):261-6.

PMID:
503453

Supplemental Content

Support Center